- 工作地点：上海
- 职位：采购助理（应届毕业生）
- 信息来源：前程无忧
说明：
此信息由前程无忧审核并发布（查看原发布网址），应届生求职网转载该信息只是出于传递更多就业招聘信息，促进大学生就业的目的。如您对此转载信息有疑义，请与原信息发布者前程无忧核实，并请同时联系本站处理该转载信息。
1. Bachelor degree or above
2. Proficient in English (both in oral and written).
3.Good in communication /interpersonal skill.
4. Careful; good in execution; extrovert; open-minded; eager to learn, down to earth.
5. Good in office software.
公司简要介绍：
Headquartered in Brussels (Belgium), UCB (ww***com[点击查看]) is a leading global biopharmaceutical company dedicated to the research, development and commercialisation of innovative pharmaceutical and biotechnology products in the fields of central nervous system disorders, allergy/respiratory diseases, immune and inflammatory disorders and oncology - UCB focuses on securing a leading position in severe disease categories. The company combines passion for innovation with a mission to provide therapeutic solutions for patients with severe diseases treated by specialists. Employing more than 8,400 people in over 40 countries, UCB achieved revenues of 2.5 billion euro in 2006. UCB is listed on the Euronext Brussels Exchange.
UCB China’s business started in 1995. Zyrtec is widely prescribed in China to treat allergy patients. Keppra, recently launched in China in 2007, is one of the top products for UCB and is a new treatment for epilepsy that has already been successfully commercialized in several countries. The revenue for Keppra in 2006 was 761 million euro (growth of 36% as compared to 2005). Today, Keppra is the most successful new treatment for epilepsy in the USA. As UCB is to expand quickly in China and with the launch of new products in the fields of Allergy and Central Nervous System (CNS), we are inviting high-caliber individuals to join UCB China.
全球领先的生物制药企业--比利时优时比制药公司（UCB）始建于1928年，总部设在比利时布鲁塞尔，在八十年的发展中，致力于为重症患者提供更多的创新治疗方法。
优时比制药在华机构包括优时比贸易（上海）有限公司和珠海许瓦兹制药有限公司，业务遍及全国，产品涉及中枢神经系统疾病、变应性疾病、心血管疾病、贫血和疼痛治疗等领域。由于公司在中国业务高速发展的需要，我们诚邀各路人才加入，与我们在中国一同成长。
To apply, please send resumes in English and Chinese with details of qualifications, experience, current and expected salary, together with a recent photograph to:
地址：上海市西藏中路268号2802室
优时比贸易（上海）有限公司 人力资源部 收 邮编：200001
E-mail: ucbcn.hr@
请务必在电子邮件的主题和信封的左下角注明所应聘的职位。如无面试通知，来电来访恕不接待。
UCB China’s business started in 1995. Zyrtec is widely prescribed in China to treat allergy patients. Keppra, recently launched in China in 2007, is one of the top products for UCB and is a new treatment for epilepsy that has already been successfully commercialized in several countries. The revenue for Keppra in 2006 was 761 million euro (growth of 36% as compared to 2005). Today, Keppra is the most successful new treatment for epilepsy in the USA. As UCB is to expand quickly in China and with the launch of new products in the fields of Allergy and Central Nervous System (CNS), we are inviting high-caliber individuals to join UCB China.
全球领先的生物制药企业--比利时优时比制药公司（UCB）始建于1928年，总部设在比利时布鲁塞尔，在八十年的发展中，致力于为重症患者提供更多的创新治疗方法。
优时比制药在华机构包括优时比贸易（上海）有限公司和珠海许瓦兹制药有限公司，业务遍及全国，产品涉及中枢神经系统疾病、变应性疾病、心血管疾病、贫血和疼痛治疗等领域。由于公司在中国业务高速发展的需要，我们诚邀各路人才加入，与我们在中国一同成长。
To apply, please send resumes in English and Chinese with details of qualifications, experience, current and expected salary, together with a recent photograph to:
地址：上海市西藏中路268号2802室
优时比贸易（上海）有限公司 人力资源部 收 邮编：200001
E-mail: ucbcn.hr@
请务必在电子邮件的主题和信封的左下角注明所应聘的职位。如无面试通知，来电来访恕不接待。
人若勇敢就是自己最好的朋友。 YingJieSheng.COM
